Search Results

Alpha Teknova, Inc., and Sartorius BIA Separations, which is part of the international life science group Sartorius, shared new data that demonstrates the ability to improve the recovery of full AAV capsids during anion-exchange purification, which will help gene therapy companies streamline the downstream processing workflow.

Biotech company, Cytomos (www.cytomotos.com) is pleased to announce that it has been selected to showcase its dielectric spectroscopy (CDS) platform at the BIA’s BioProcessUK Dragon’s Den

Alpha Teknova, Inc., and Sartorius BIA Separations, which is part of the international life science group Sartorius, announced that the companies have entered into a collaboration arrangement that will help gene therapy companies streamline the downstream purification process.

This is part one of a discussion focused upon data bias, accuracy, access and the future of AI in drug development. Topics explored are ROI, human bias, data challenges, data management plans, and human expertise.

Precedence Research Says, the global cell separation market size was valued at USD 10.92 billion in 2023 and it is increasing over USD 38.99 billion by 2033 with a CAGR of 13.54% from 2024 to 2033.

BioNet, a leading biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of Sartorius, a leading biochromatography development and manufacturing company, announced the successful development of an optimized mRNA manufacturing process.